{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2026:MEDU4U2WGBFVWSYCARTZAELJE2","short_pith_number":"pith:MEDU4U2W","canonical_record":{"source":{"id":"2605.17208","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"q-bio.PE","submitted_at":"2026-05-17T00:50:01Z","cross_cats_sorted":[],"title_canon_sha256":"55c5315d506d8628df8a78d7466bee2c5f0cdfbb058626b602485aed725a0f0b","abstract_canon_sha256":"9ca9d4b6571dcbc2b09d9f560c35552c6bac3e4b2952fd267aef0db813321fdb"},"schema_version":"1.0"},"canonical_sha256":"61074e5356304b5b4b020467901169269e37a446be7268b81f2c4fe8373dee33","source":{"kind":"arxiv","id":"2605.17208","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2605.17208","created_at":"2026-05-20T00:03:45Z"},{"alias_kind":"arxiv_version","alias_value":"2605.17208v1","created_at":"2026-05-20T00:03:45Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2605.17208","created_at":"2026-05-20T00:03:45Z"},{"alias_kind":"pith_short_12","alias_value":"MEDU4U2WGBFV","created_at":"2026-05-20T00:03:45Z"},{"alias_kind":"pith_short_16","alias_value":"MEDU4U2WGBFVWSYC","created_at":"2026-05-20T00:03:45Z"},{"alias_kind":"pith_short_8","alias_value":"MEDU4U2W","created_at":"2026-05-20T00:03:45Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2026:MEDU4U2WGBFVWSYCARTZAELJE2","target":"record","payload":{"canonical_record":{"source":{"id":"2605.17208","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"q-bio.PE","submitted_at":"2026-05-17T00:50:01Z","cross_cats_sorted":[],"title_canon_sha256":"55c5315d506d8628df8a78d7466bee2c5f0cdfbb058626b602485aed725a0f0b","abstract_canon_sha256":"9ca9d4b6571dcbc2b09d9f560c35552c6bac3e4b2952fd267aef0db813321fdb"},"schema_version":"1.0"},"canonical_sha256":"61074e5356304b5b4b020467901169269e37a446be7268b81f2c4fe8373dee33","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-20T00:03:45.278657Z","signature_b64":"zf7REwLTKiOcXIec4s74yH01lm3OaUQF3RwKduJJa7D7MlFtP/1DYjIVWJv3wQ3+V4AzX8nttKnstpV3JIqeBQ==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"61074e5356304b5b4b020467901169269e37a446be7268b81f2c4fe8373dee33","last_reissued_at":"2026-05-20T00:03:45.277809Z","signature_status":"signed_v1","first_computed_at":"2026-05-20T00:03:45.277809Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"2605.17208","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-20T00:03:45Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"SVlSpN9/6GktUB0+95aD38nFplg0GzNB6OXT8DbnqdSQzS7fuXcXTFZwj3xUdtPEP8G67BPtc7yiEQIWoKjtBw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-10T22:47:13.304180Z"},"content_sha256":"f42aff612f00e19ee4fb136bd57dc35c0e4d0652fe55f2345ed0c6ff5e582ebf","schema_version":"1.0","event_id":"sha256:f42aff612f00e19ee4fb136bd57dc35c0e4d0652fe55f2345ed0c6ff5e582ebf"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2026:MEDU4U2WGBFVWSYCARTZAELJE2","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Modeling tumor cell heterogeneity and plasticity in adaptive therapy","license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","headline":"A mathematical model with continuous drug susceptibility shows adaptive therapy controls tumors longer than fixed dosing by regulating sensitive cell populations.","cross_cats":[],"primary_cat":"q-bio.PE","authors_text":"Chenghang Li, Jinzhi Lei, Rui Yue","submitted_at":"2026-05-17T00:50:01Z","abstract_excerpt":"Adaptive therapy (AT) is designed to postpone the emergence of drug resistance by exploiting evolutionary competition among tumor subclones. Most mathematical models of AT assume a binary population structure of drug-sensitive and drug-resistant cells, which neglects the continuous nature of phenotypic plasticity. In this study, we propose a mathematical model that integrates a continuous drug susceptibility index with a probabilistic inheritance function to describe clonal dynamics under therapy. The resulting integro-differential system generalizes traditional two-type competition models and"},"claims":{"count":4,"items":[{"kind":"strongest_claim","text":"Analytical and numerical studies show that (i) continuous therapy drives rapid expansion of resistant clones, (ii) adaptive therapy maintains long-term tumor control by dynamically regulating sensitive populations, and (iii) high phenotypic plasticity accelerates phenotype switching, leading to earlier tumor relapse following continuous therapy.","source":"verdict.strongest_claim","status":"machine_extracted","claim_id":"C1","attestation":"unclaimed"},{"kind":"weakest_assumption","text":"The probabilistic inheritance function and continuous drug susceptibility index are assumed to sufficiently represent real biological plasticity and heterogeneity in tumor cells, as stated in the model proposal without reference to specific empirical calibration or validation data.","source":"verdict.weakest_assumption","status":"machine_extracted","claim_id":"C2","attestation":"unclaimed"},{"kind":"one_line_summary","text":"An integro-differential model with continuous phenotypic plasticity shows adaptive therapy outperforms continuous regimens by exploiting competition between sensitive and resistant clones, with high plasticity accelerating relapse under fixed therapy.","source":"verdict.one_line_summary","status":"machine_extracted","claim_id":"C3","attestation":"unclaimed"},{"kind":"headline","text":"A mathematical model with continuous drug susceptibility shows adaptive therapy controls tumors longer than fixed dosing by regulating sensitive cell populations.","source":"verdict.pith_extraction.headline","status":"machine_extracted","claim_id":"C4","attestation":"unclaimed"}],"snapshot_sha256":"86cbf8ab527f4672fb4612cf88d828ffccf5b59113031c70961b502ddb53a4ff"},"source":{"id":"2605.17208","kind":"arxiv","version":1},"verdict":{"id":"27179d36-5da7-47c8-b988-6f1f6382fdd5","model_set":{"reader":"grok-4.3"},"created_at":"2026-05-19T23:20:24.040797Z","strongest_claim":"Analytical and numerical studies show that (i) continuous therapy drives rapid expansion of resistant clones, (ii) adaptive therapy maintains long-term tumor control by dynamically regulating sensitive populations, and (iii) high phenotypic plasticity accelerates phenotype switching, leading to earlier tumor relapse following continuous therapy.","one_line_summary":"An integro-differential model with continuous phenotypic plasticity shows adaptive therapy outperforms continuous regimens by exploiting competition between sensitive and resistant clones, with high plasticity accelerating relapse under fixed therapy.","pipeline_version":"pith-pipeline@v0.9.0","weakest_assumption":"The probabilistic inheritance function and continuous drug susceptibility index are assumed to sufficiently represent real biological plasticity and heterogeneity in tumor cells, as stated in the model proposal without reference to specific empirical calibration or validation data.","pith_extraction_headline":"A mathematical model with continuous drug susceptibility shows adaptive therapy controls tumors longer than fixed dosing by regulating sensitive cell populations."},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2605.17208/integrity.json","findings":[],"available":true,"detectors_run":[{"name":"doi_compliance","ran_at":"2026-05-19T23:31:29.726108Z","status":"completed","version":"1.0.0","findings_count":0},{"name":"doi_title_agreement","ran_at":"2026-05-19T23:31:20.404783Z","status":"completed","version":"1.0.0","findings_count":0},{"name":"ai_meta_artifact","ran_at":"2026-05-19T22:33:23.727780Z","status":"skipped","version":"1.0.0","findings_count":0},{"name":"claim_evidence","ran_at":"2026-05-19T22:01:57.933994Z","status":"completed","version":"1.0.0","findings_count":0}],"snapshot_sha256":"84ae19dce0c2dab5cbd2ddc2b2fc6897eccf3e50d3037b8cd1109bb5c59a5775"},"references":{"count":34,"sample":[{"doi":"","year":2020,"title":"Siegel, Mathieu Laversanne, Isabelle Soerjo- mataram, Ahmedin Jemal, and Freddie Bray","work_id":"ca9f4fe0-e939-4a32-bb5c-8b0f89348e0f","ref_index":1,"cited_arxiv_id":"","is_internal_anchor":false},{"doi":"","year":2012,"title":"Mel Greaves and Carlo C. Maley. Clonal evolution in cancer.Nature, 481(7381):306–313, January 2012","work_id":"5da70b04-0e35-4529-a9e2-ff382041c93a","ref_index":2,"cited_arxiv_id":"","is_internal_anchor":false},{"doi":"","year":2009,"title":"Robert A. Gatenby, Ariosto S. Silva, Robert J. Gillies, and B. Roy Frieden. Adaptive therapy.Cancer Res, 69(11):4894–4903, June 2009","work_id":"b3698c11-ab04-444d-bff5-359422c65d6e","ref_index":3,"cited_arxiv_id":"","is_internal_anchor":false},{"doi":"","year":2020,"title":"Gatenby and Joel S","work_id":"c213046c-be7e-4a99-80ad-193e3833ef1f","ref_index":4,"cited_arxiv_id":"","is_internal_anchor":false},{"doi":"","year":2013,"title":"Athena Aktipis and Randolph M","work_id":"a2daed0c-3b21-417e-b9e9-1e51b48e2e30","ref_index":5,"cited_arxiv_id":"","is_internal_anchor":false}],"resolved_work":34,"snapshot_sha256":"81e38305caaa19e0fb3bad3dee1f7e93f435d5c41d0a9ddf8ba361db3aebc5ba","internal_anchors":0},"formal_canon":{"evidence_count":2,"snapshot_sha256":"695fb1556278465724444bdae0b3106d8806bc577f722c40709579ad0642c798"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":"27179d36-5da7-47c8-b988-6f1f6382fdd5"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-20T00:03:45Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"G+hSGdNDFRyRewU2Oo5lTDM25wGWjtp4Jf6lbyAr4h5nbdr3NBjHZJW2ouvD9X4ux7VrddXJtO1pGF9qQfMoDA==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-10T22:47:13.304882Z"},"content_sha256":"e6eae3f95ee4a2caeab1ecb0802f4d692cfe0125cc3cb8f0481b7b27e1da753b","schema_version":"1.0","event_id":"sha256:e6eae3f95ee4a2caeab1ecb0802f4d692cfe0125cc3cb8f0481b7b27e1da753b"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/MEDU4U2WGBFVWSYCARTZAELJE2/bundle.json","state_url":"https://pith.science/pith/MEDU4U2WGBFVWSYCARTZAELJE2/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/MEDU4U2WGBFVWSYCARTZAELJE2/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-06-10T22:47:13Z","links":{"resolver":"https://pith.science/pith/MEDU4U2WGBFVWSYCARTZAELJE2","bundle":"https://pith.science/pith/MEDU4U2WGBFVWSYCARTZAELJE2/bundle.json","state":"https://pith.science/pith/MEDU4U2WGBFVWSYCARTZAELJE2/state.json","well_known_bundle":"https://pith.science/.well-known/pith/MEDU4U2WGBFVWSYCARTZAELJE2/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2026:MEDU4U2WGBFVWSYCARTZAELJE2","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"9ca9d4b6571dcbc2b09d9f560c35552c6bac3e4b2952fd267aef0db813321fdb","cross_cats_sorted":[],"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"q-bio.PE","submitted_at":"2026-05-17T00:50:01Z","title_canon_sha256":"55c5315d506d8628df8a78d7466bee2c5f0cdfbb058626b602485aed725a0f0b"},"schema_version":"1.0","source":{"id":"2605.17208","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2605.17208","created_at":"2026-05-20T00:03:45Z"},{"alias_kind":"arxiv_version","alias_value":"2605.17208v1","created_at":"2026-05-20T00:03:45Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2605.17208","created_at":"2026-05-20T00:03:45Z"},{"alias_kind":"pith_short_12","alias_value":"MEDU4U2WGBFV","created_at":"2026-05-20T00:03:45Z"},{"alias_kind":"pith_short_16","alias_value":"MEDU4U2WGBFVWSYC","created_at":"2026-05-20T00:03:45Z"},{"alias_kind":"pith_short_8","alias_value":"MEDU4U2W","created_at":"2026-05-20T00:03:45Z"}],"graph_snapshots":[{"event_id":"sha256:e6eae3f95ee4a2caeab1ecb0802f4d692cfe0125cc3cb8f0481b7b27e1da753b","target":"graph","created_at":"2026-05-20T00:03:45Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":4,"items":[{"attestation":"unclaimed","claim_id":"C1","kind":"strongest_claim","source":"verdict.strongest_claim","status":"machine_extracted","text":"Analytical and numerical studies show that (i) continuous therapy drives rapid expansion of resistant clones, (ii) adaptive therapy maintains long-term tumor control by dynamically regulating sensitive populations, and (iii) high phenotypic plasticity accelerates phenotype switching, leading to earlier tumor relapse following continuous therapy."},{"attestation":"unclaimed","claim_id":"C2","kind":"weakest_assumption","source":"verdict.weakest_assumption","status":"machine_extracted","text":"The probabilistic inheritance function and continuous drug susceptibility index are assumed to sufficiently represent real biological plasticity and heterogeneity in tumor cells, as stated in the model proposal without reference to specific empirical calibration or validation data."},{"attestation":"unclaimed","claim_id":"C3","kind":"one_line_summary","source":"verdict.one_line_summary","status":"machine_extracted","text":"An integro-differential model with continuous phenotypic plasticity shows adaptive therapy outperforms continuous regimens by exploiting competition between sensitive and resistant clones, with high plasticity accelerating relapse under fixed therapy."},{"attestation":"unclaimed","claim_id":"C4","kind":"headline","source":"verdict.pith_extraction.headline","status":"machine_extracted","text":"A mathematical model with continuous drug susceptibility shows adaptive therapy controls tumors longer than fixed dosing by regulating sensitive cell populations."}],"snapshot_sha256":"86cbf8ab527f4672fb4612cf88d828ffccf5b59113031c70961b502ddb53a4ff"},"formal_canon":{"evidence_count":2,"snapshot_sha256":"695fb1556278465724444bdae0b3106d8806bc577f722c40709579ad0642c798"},"integrity":{"available":true,"clean":true,"detectors_run":[{"findings_count":0,"name":"doi_compliance","ran_at":"2026-05-19T23:31:29.726108Z","status":"completed","version":"1.0.0"},{"findings_count":0,"name":"doi_title_agreement","ran_at":"2026-05-19T23:31:20.404783Z","status":"completed","version":"1.0.0"},{"findings_count":0,"name":"ai_meta_artifact","ran_at":"2026-05-19T22:33:23.727780Z","status":"skipped","version":"1.0.0"},{"findings_count":0,"name":"claim_evidence","ran_at":"2026-05-19T22:01:57.933994Z","status":"completed","version":"1.0.0"}],"endpoint":"/pith/2605.17208/integrity.json","findings":[],"snapshot_sha256":"84ae19dce0c2dab5cbd2ddc2b2fc6897eccf3e50d3037b8cd1109bb5c59a5775","summary":{"advisory":0,"by_detector":{},"critical":0,"informational":0}},"paper":{"abstract_excerpt":"Adaptive therapy (AT) is designed to postpone the emergence of drug resistance by exploiting evolutionary competition among tumor subclones. Most mathematical models of AT assume a binary population structure of drug-sensitive and drug-resistant cells, which neglects the continuous nature of phenotypic plasticity. In this study, we propose a mathematical model that integrates a continuous drug susceptibility index with a probabilistic inheritance function to describe clonal dynamics under therapy. The resulting integro-differential system generalizes traditional two-type competition models and","authors_text":"Chenghang Li, Jinzhi Lei, Rui Yue","cross_cats":[],"headline":"A mathematical model with continuous drug susceptibility shows adaptive therapy controls tumors longer than fixed dosing by regulating sensitive cell populations.","license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"q-bio.PE","submitted_at":"2026-05-17T00:50:01Z","title":"Modeling tumor cell heterogeneity and plasticity in adaptive therapy"},"references":{"count":34,"internal_anchors":0,"resolved_work":34,"sample":[{"cited_arxiv_id":"","doi":"","is_internal_anchor":false,"ref_index":1,"title":"Siegel, Mathieu Laversanne, Isabelle Soerjo- mataram, Ahmedin Jemal, and Freddie Bray","work_id":"ca9f4fe0-e939-4a32-bb5c-8b0f89348e0f","year":2020},{"cited_arxiv_id":"","doi":"","is_internal_anchor":false,"ref_index":2,"title":"Mel Greaves and Carlo C. Maley. Clonal evolution in cancer.Nature, 481(7381):306–313, January 2012","work_id":"5da70b04-0e35-4529-a9e2-ff382041c93a","year":2012},{"cited_arxiv_id":"","doi":"","is_internal_anchor":false,"ref_index":3,"title":"Robert A. Gatenby, Ariosto S. Silva, Robert J. Gillies, and B. Roy Frieden. Adaptive therapy.Cancer Res, 69(11):4894–4903, June 2009","work_id":"b3698c11-ab04-444d-bff5-359422c65d6e","year":2009},{"cited_arxiv_id":"","doi":"","is_internal_anchor":false,"ref_index":4,"title":"Gatenby and Joel S","work_id":"c213046c-be7e-4a99-80ad-193e3833ef1f","year":2020},{"cited_arxiv_id":"","doi":"","is_internal_anchor":false,"ref_index":5,"title":"Athena Aktipis and Randolph M","work_id":"a2daed0c-3b21-417e-b9e9-1e51b48e2e30","year":2013}],"snapshot_sha256":"81e38305caaa19e0fb3bad3dee1f7e93f435d5c41d0a9ddf8ba361db3aebc5ba"},"source":{"id":"2605.17208","kind":"arxiv","version":1},"verdict":{"created_at":"2026-05-19T23:20:24.040797Z","id":"27179d36-5da7-47c8-b988-6f1f6382fdd5","model_set":{"reader":"grok-4.3"},"one_line_summary":"An integro-differential model with continuous phenotypic plasticity shows adaptive therapy outperforms continuous regimens by exploiting competition between sensitive and resistant clones, with high plasticity accelerating relapse under fixed therapy.","pipeline_version":"pith-pipeline@v0.9.0","pith_extraction_headline":"A mathematical model with continuous drug susceptibility shows adaptive therapy controls tumors longer than fixed dosing by regulating sensitive cell populations.","strongest_claim":"Analytical and numerical studies show that (i) continuous therapy drives rapid expansion of resistant clones, (ii) adaptive therapy maintains long-term tumor control by dynamically regulating sensitive populations, and (iii) high phenotypic plasticity accelerates phenotype switching, leading to earlier tumor relapse following continuous therapy.","weakest_assumption":"The probabilistic inheritance function and continuous drug susceptibility index are assumed to sufficiently represent real biological plasticity and heterogeneity in tumor cells, as stated in the model proposal without reference to specific empirical calibration or validation data."}},"verdict_id":"27179d36-5da7-47c8-b988-6f1f6382fdd5"}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:f42aff612f00e19ee4fb136bd57dc35c0e4d0652fe55f2345ed0c6ff5e582ebf","target":"record","created_at":"2026-05-20T00:03:45Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"9ca9d4b6571dcbc2b09d9f560c35552c6bac3e4b2952fd267aef0db813321fdb","cross_cats_sorted":[],"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"q-bio.PE","submitted_at":"2026-05-17T00:50:01Z","title_canon_sha256":"55c5315d506d8628df8a78d7466bee2c5f0cdfbb058626b602485aed725a0f0b"},"schema_version":"1.0","source":{"id":"2605.17208","kind":"arxiv","version":1}},"canonical_sha256":"61074e5356304b5b4b020467901169269e37a446be7268b81f2c4fe8373dee33","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"61074e5356304b5b4b020467901169269e37a446be7268b81f2c4fe8373dee33","first_computed_at":"2026-05-20T00:03:45.277809Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-20T00:03:45.277809Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"zf7REwLTKiOcXIec4s74yH01lm3OaUQF3RwKduJJa7D7MlFtP/1DYjIVWJv3wQ3+V4AzX8nttKnstpV3JIqeBQ==","signature_status":"signed_v1","signed_at":"2026-05-20T00:03:45.278657Z","signed_message":"canonical_sha256_bytes"},"source_id":"2605.17208","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:f42aff612f00e19ee4fb136bd57dc35c0e4d0652fe55f2345ed0c6ff5e582ebf","sha256:e6eae3f95ee4a2caeab1ecb0802f4d692cfe0125cc3cb8f0481b7b27e1da753b"],"state_sha256":"d068c2b44a729a2b2538d7d0cf85488b9211cfbbc6c9adb987586933b6baf9a1"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"EYUhMm6TwO9lcJAsC+AWJKdV8wgI/lnsl9VYI5Gx2S584MhDiQuzYddNra9umrRUy9YlfnjVTIRHiuew6TyPCQ==","signed_message":"bundle_sha256_bytes","signed_at":"2026-06-10T22:47:13.307921Z","bundle_sha256":"d17fa48bed50acda2710a28aadf2b665b2d21e5992cd4c1718a13bb682d6f7ca"}}